PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Ganirelix Acetate Injection | 250mcg/0.5mL |
![]() |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
Bromfenac Ophthalmic Solution 0.075% | 0.075% |
![]() |
5ml |
68180-434-01 |
Bromsite® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
Bromfenac Ophthalmic Solution 0.09% | 0.09% |
![]() |
1.7mL |
68180-436-01 |
Bromday® |
AT2 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
Doxycycline Capsules | 40mg |
![]() |
30 |
70748-308-06 |
Oracea® |
AB |
Antibiotic |
Mirabegron Extended-Release Tablets | 25mg |
![]() |
30 |
68180-152-09 |
Myrbetriq® |
– |
Beta-3 Adrenergic Agonist |
Doxycycline for Injection USP | 100mg/ vial |
![]() |
(10) single-dose vials |
70748-338-10 |
Vibramycin® |
AP |
Tetracycline Antibiotics |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.